Quantcast

Transplant Program Tops in Expected One-Year Survival Rate

January 22, 2009

SEATTLE, Jan. 22 /PRNewswire/ — Fred Hutchinson Cancer Research Center’s
stem-cell transplant program at the Seattle Cancer Care Alliance (SCCA) was
one of only two transplant programs nationwide that consistently outperformed
the expected one-year survival rate for unrelated donor transplants, according
to an independent report that assessed 122 transplant centers over a five-year
period.

The Center for International Blood and Marrow Transplant Registry examined
the survival rates of 8,847 transplants performed to treat blood cancers at
U.S. centers in the National Marrow Donor Program (NMDP) network. The
survival data was collected for the years 2002 through 2006 and patient
outcomes were measured at the end of 2007. In each of five years, the
Hutchinson Center “over performed” in terms of expected one-year survival
rates after transplant. Only one other transplant center in the nation
matched that record. The data was adjusted for several risk factors that
could influence patient outcomes such as type of disease, its stage, patient
age and degree of donor cell match.

Stem-cell and bone-marrow transplants are used to treat various leukemias,
lymphomas and severe aplastic anemia.

“The study’s findings reflect the extraordinary and longtime dedication by
the staff of the Hutchinson Center and SCCA to improve the outcomes of our
patients by continually refining transplantation to be a safer and more
effective treatment,” said Fred Appelbaum, M.D., executive director of the
SCCA and director of the Hutchinson Center’s Clinical Research Division.

The clinical use of bone-marrow and stem-cell transplantation was first
developed at the Hutchinson Center and, subsequently, most of its
practitioners were trained there. Patients who choose to have their
transplants done at centers that do a high number of such procedures generally
have better outcomes.

Required by federal law, the registry’s annual report is designed to
provide potential stem-cell transplant recipients, their families and the
public with comparative survival rates among the transplant centers in the
NMDP network.

About Seattle Cancer Care Alliance

Seattle Cancer Care Alliance, established in 1998, unites the adult and
pediatric cancer-care services of Fred Hutchinson Cancer Research Center, UW
Medicine and Children’s Hospital and Regional Medical Center. A major focus
of SCCA is to speed the transfer of new diagnostic and treatment techniques
from the research setting to the patient bedside while providing premier,
patient-focused cancer care. Patients who come to SCCA receive the latest
research-based cancer therapies as well as cutting-edge treatments for a
number of non-malignant diseases under development by its partner
organizations. SCCA has three clinical-care sites: an outpatient clinic on the
Fred Hutchinson campus, a pediatric-inpatient unit at Children’s and an
adult-inpatient unit at UW Medical Center. For more information about SCCA,
visit http://www.seattlecca.org.

Media Contact:

Dean Forbes, (206) 667-289

SOURCE Seattle Cancer Care Alliance


Source: newswire



comments powered by Disqus